This inventor holds 1 USPTO granted patent. Top assignee: Nanjing Noratech Pharmaceuticals Co., Ltd. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Innovations of Wei-Ming Jiang in Pharmaceutical Development
Introduction
Wei-Ming Jiang is a notable inventor based in Nanjing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new drug formulations. His work focuses on improving the efficacy and safety of medications used to treat central nervous system diseases.
Latest Patents
Wei-Ming Jiang holds a patent for a crystalline form of aripiprazole. This invention relates to a crystalline form N of aripiprazole, pharmaceutical compositions thereof, and the use of crystalline form N in the preparation of a medicament for the treatment of central nervous system diseases, especially schizophrenia. This innovation is crucial for enhancing the therapeutic options available for patients suffering from these conditions.
Career Highlights
Wei-Ming Jiang is associated with Nanjing Noratech Pharmaceuticals Co., Ltd. His role in the company has allowed him to focus on research and development, leading to advancements in pharmaceutical technologies. His dedication to innovation has positioned him as a key figure in the industry.
Collaborations
Wei-Ming Jiang has collaborated with notable colleagues, including Yun-Zhe Sun and Xin Zhao. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in their projects.
Conclusion
Wei-Ming Jiang's contributions to pharmaceutical development, particularly through his patent on aripiprazole, highlight his commitment to improving treatment options for central nervous system diseases. His work continues to impact the field positively, showcasing the importance of innovation in healthcare.